Lifeway Foods® CEO Julie Smolyansky to Appear with Katie Couric at the SHE Media Co-Lab at SXSW® to Discuss Gut Health Trends and History of Lifeway Kefir

Rhea-AI Summary

Lifeway Foods (Nasdaq: LWAY) announced that CEO Julie Smolyansky will join Katie Couric at SXSW on March 8th, 2025, to discuss gut health trends and the company's history. The event will take place at 10:15am at the She Media Lounge in Austin, TX.

The discussion comes amid new research from Mass General Brigham showing that consuming two or more servings of fermented dairy weekly led to a 20% reduction in Bifidobacterium-positive colorectal cancer incidence over three decades. The study highlights the potential benefits of live bacterial cultures in fermented milk products for gut health and cancer risk reduction.

As America's leading kefir supplier, Lifeway Kefir contains 12 live and active cultures, protein, calcium, and vitamin D, supporting overall wellness and gut flora balance.

Positive

• Scientific validation of fermented dairy products' health benefits supports company's market position
• Leading market position in US kefir market

Negative

• None.

Leading kefir brand seeks to raise awareness around new gut health research, applauds study linking long-term fermented milk consumption to lower colorectal cancer risk

MORTON GROVE, Ill., March 3, 2025 /PRNewswire/ -- Lifeway Foods, Inc. (Nasdaq: LWAY), a leading U.S. supplier of kefir and fermented probiotic products, announced today that Lifeway President and CEO Julie Smolyansky will appear with Katie Couric at the SXSW conference to discuss the company's history, innovations in microbiome research and the importance of gut healthy foods and habits. The event will occur on March 8th at 10:15am at the She Media Lounge, located at 304 East 3rd Street in Austin, TX.

"I am excited to return to SXSW this year to share the Lifeway story and discuss the latest gut health research with Katie Couric, a news industry icon who serves as an inspiration for so many," said Ms. Smolyansky. "SXSW is an amazing venue to explore ideas because the audience is curious and attuned to the current trends in science, culture and the arts. I'm grateful to share the stage with such an influential journalist in this high-profile setting."

An important topic of the discussion will be the rise in colorectal cancer. Lifeway applauds the recent study led by investigators from Mass General Brigham titled, "Long-Term Yogurt Consumption Tied to Decreased Incidence of Certain Types of Colorectal Cancer." The study followed participants for over three decades, revealing that those who consumed two or more servings of fermented dairy per week experienced a 20% reduction in the incidence of colorectal cancer positive for Bifidobacterium. This breakthrough emphasizes the potential role that the live bacterial cultures in fermented milk products, such as kefir and yogurt, may play in supporting gut health and reducing cancer risk. 

In the release distributed from Mass General Brigham which highlighted the study's findings, co-senior author of the research Tomotaka Ugai, MD, PhD, of the Department of Pathology at the Brigham and the Department of Epidemiology at the Harvard T.H. Chan School of Public Health stated, "it has long been believed that yogurt and other fermented milk products are beneficial for gastrointestinal health. Our new findings suggest that this protective effect may be specific for Bifidobacterium-positive tumors."

"We applaud Dr. Ugai, his co-authors and team of researchers who uncovered this new evidence further supporting the connection between diet, our gut microbiome and various health risks," said Ms. Smolyansky. 

"Lifeway's mission is to enable people to live healthier by providing them with fermented milk products featuring high-quality bioavailable nutrients. We are proud to see the scientific community validate the health benefits of probiotic-rich foods, and this research serves as a powerful reminder of the vital role our diet and nutrition play in supporting long-term health." 

As America's leading supplier of kefir, Lifeway Kefir is made with 12 live and active cultures, and packed with protein, calcium and vitamin D. Each product is loaded with probiotics to support overall wellness and maintain a healthy gut flora balance.

To view the full study published by Mass General Brigham, visit: https://www.tandfonline.com/doi/full/10.1080/19490976.2025.2452237#d1e2237.

For more information about Lifeway and its products, visit lifewayfoods.com

Contacts:
Perceptual Advisors
Dan Tarman
Email: dtarman@perceptualadvisors.com

Derek Miller
Vice President of Communications, Lifeway Foods
Email: derekm@lifeway.net 

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/lifeway-foods-ceo-julie-smolyansky-to-appear-with-katie-couric-at-the-she-media-co-lab-at-sxsw-to-discuss-gut-health-trends-and-history-of-lifeway-kefir-302390500.html

SOURCE Lifeway Foods, Inc.

FAQ

What are the key findings of the Mass General Brigham study regarding fermented dairy and colorectal cancer?

The study found that consuming 2+ servings of fermented dairy weekly resulted in a 20% reduction in Bifidobacterium-positive colorectal cancer over three decades.

When and where will Lifeway Foods (LWAY) CEO speak at SXSW 2025?

CEO Julie Smolyansky will speak on March 8th, 2025, at 10:15am at the She Media Lounge, 304 East 3rd Street in Austin, TX.

What are the main health benefits of Lifeway Kefir products?

Lifeway Kefir contains 12 live and active cultures, protein, calcium, and vitamin D, supporting gut health and overall wellness.

How does the new research support LWAY's business strategy?

The research validates Lifeway's mission of providing fermented milk products with health benefits, specifically showing their potential role in reducing colorectal cancer risk.